Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression

The death receptor Fas (Apo1/CD95) and Fas ligand (FasL) system is recognised as a major pathway for the induction of apoptosis in vivo, and antiapoptosis via its blockade plays a critical role in carcinogenesis and progression in several malignancies. However, the function of Fas–FasL system in uro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamana, K, Bilim, V, Hara, N, Kasahara, T, Itoi, T, Maruyama, R, Nishiyama, T, Takahashi, K, Tomita, Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361597/
https://www.ncbi.nlm.nih.gov/pubmed/16091761
http://dx.doi.org/10.1038/sj.bjc.6602732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361597/
https://www.ncbi.nlm.nih.gov/pubmed/16091761
http://dx.doi.org/10.1038/sj.bjc.6602732

Ejemplares similares